Akili, Inc.
AKLIDelisted Jul 2, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001850266
Akili, Inc. was delisted on Jul 2, 2024; its insiders filed their last Form 4 on Jul 8, 2024; 35 institutions reported holding it in 13F filings for Q2 2024, worth $20.4M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 35
- Q2 2024, +1 vs. previous quarter
- 13F value
- $20.4M
- Reported value at the end of Q2 2024
- Superinvestors holding
- 0
- At the end of Q2 2024
Superinvestors holding AKLI, Q2 2024
No superinvestor reported holding AKLI at the end of Q2 2024.
Latest insider trades
Open-market purchases and sales by Akili, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Studer JacquelineChief Legal Officer | SSale | −1.13K | $1.05 | −$1.19K | −0.3%348.3K after | |
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Martucci Walter Edward IIChief Executive Officer | SSale | −2.35K | $1.05 | −$2.47K | −0.1%3.15M after | |
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Franklin MatthewPresident & COO | SSale | −1.73K | $1.05 | −$1.81K | −0.2%753.9K after | |
| Sep 14, 2023 (view filing) | Sep 11 | 3 daysLate | Shanbhag SantoshChief Financial Officer | SSale | −830 | $1.05 | −$871.5 | −0.3%323.6K after |
Top 10 13F holders, Q2 2024
The largest institutional positions in Akili, Inc. at the end of Q2 2024; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Social Capital Group LLC | 11,873,000 | $5.16M | 100.00% | 00.0% | Unchanged |
| Temasek Holdings (Private) Ltd | 11,509,122 | $5.00M | 0.02% | 00.0% | Unchanged |
| Beryl Capital Management LLC | 6,243,943 | $2.71M | 0.82% | +6,243,943 | New |
| Neuberger Berman Group LLC | 5,776,784 | $2.51M | 0.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 4,665,795 | $2.03M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 2,310,773 | $1.00M | 0.00% | +2,281,007+7,663.1% | Added |
| Comprehensive Financial Management LLC | 1,063,422 | $462.3K | 0.02% | 00.0% | Unchanged |
| Takeda Pharmaceutical Co Ltd | 738,819 | $321.4K | 0.14% | 00.0% | Unchanged |
| PenderFund Capital Management Ltd. | 454,970 | $270.6K | 0.07% | +454,970 | New |
| Wildcat Capital Management, LLC | 545,295 | $237.0K | 0.06% | 00.0% | Unchanged |